NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 118 filers reported holding NUVALENT INC in Q3 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,943,622 | +17.6% | 1,260,466 | +7.9% | 0.00% | 0.0% |
| Q2 2023 | $49,254,096 | +81.0% | 1,167,989 | +12.0% | 0.00% | +50.0% |
| Q1 2023 | $27,217,166 | -45.1% | 1,043,203 | -37.4% | 0.00% | +100.0% |
| Q4 2022 | $49,616,338 | +766.2% | 1,666,096 | +465.5% | 0.00% | – |
| Q3 2022 | $5,728,000 | +48.5% | 294,632 | +3.6% | 0.00% | – |
| Q2 2022 | $3,856,000 | +22.6% | 284,359 | +25.6% | 0.00% | – |
| Q1 2022 | $3,145,000 | -1.9% | 226,439 | +34.4% | 0.00% | – |
| Q4 2021 | $3,207,000 | +2.4% | 168,453 | +21.3% | 0.00% | – |
| Q3 2021 | $3,132,000 | – | 138,911 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,341,024 | $368,253,000 | 7.72% |
| Fairmount Funds Management LLC | 914,614 | $17,414,000 | 5.74% |
| Bain Capital Life Sciences Investors, LLC | 3,428,014 | $65,269,000 | 5.18% |
| VR Adviser, LLC | 803,951 | $15,307,000 | 2.09% |
| Boxer Capital, LLC | 1,210,192 | $23,042,000 | 0.90% |
| Avoro Capital Advisors LLC | 1,102,671 | $18,431,000 | 0.31% |
| BVF INC/IL | 448,512 | $8,540,000 | 0.31% |
| Logos Global Management LP | 134,650 | $2,563,000 | 0.26% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,180,696 | $22,480,000 | 0.23% |
| Perceptive Advisors | 1,500,000 | $28,560,000 | 0.22% |